You are here

funding

Bristol Myers-backed TORL secures $158M to march army of ADCs through clinic

Fierce Biotech

Wed, 04/10/24 - 09:52 am

Bristol Myers Squibb

TORL BioTherapeutics

antibody-drug conjugate

Karuna's captains set sail in new neuropsychiatric venture called Seaport Therapeutics

Fierce Biotech

Tue, 04/9/24 - 11:43 am

Karuna Therapeutics

Seaport Therapeutics

PureTech Health

Private biotech funding ticks up as venture firms deploy cash

BioPharma Dive

Mon, 04/8/24 - 05:46 pm

venture capital

A dementia-focused VC digs past amyloid for new kinds of brain drugs

BioPharma Dive

Wed, 04/3/24 - 11:21 am

venture capital

Dementia Discovery Fund

Alzheimer's disease

Diagonal starts up with $128M to make better ‘activator’ antibody drugs

BioPharma Dive

Wed, 04/3/24 - 11:05 am

Diagonal Therapeutics

activator antibodies

Moderna Secures Up to $750M in Funding from Blackstone to Advance Flu Program

BioSpace

Wed, 03/27/24 - 11:19 am

Moderna Therapeutics

Investors fund Prometheus team's 'unfinished business' with $400M for new inflammatory biotech Mirador

Fierce Biotech

Thu, 03/21/24 - 11:27 am

Prometheus Biosciences

Capstan heats up ‘in vivo’ cell therapy chase with $175M fundraise

BioPharma Dive

Wed, 03/20/24 - 11:35 am

Capstan Therapeutics

Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers

BioSpace

Wed, 03/20/24 - 11:28 am

Clasp Therapeutics

Engrail closes $157M series B, fueled by investors' renewed interest in neuropsychiatry

Fierce Biotech

Tue, 03/19/24 - 11:58 am

Engrail Therapeutics

neuropsychiatric

Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch

BioSpace

Tue, 03/19/24 - 11:22 am

sickle cell disease

Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer

BioSpace

Sun, 03/17/24 - 09:25 pm

Asgard Therapeutics

Boehringer Ingelheim

immuno-oncology

ADC Biotech Tubulis Closes Upsized $138M Financing Round

BioSpace

Thu, 03/14/24 - 06:16 pm

antibody-drug conjugate

Pfizer-backed Mission raises £25.2m to progress clinical development of key drugs

Business Weekly

Thu, 03/14/24 - 11:28 am

Mission Therapeutics

Biotech stock fundings headed for best quarter in 3 years, Jefferies says

BioPharma Dive

Mon, 03/11/24 - 11:46 am

Biopharma VC Funding Value Dropped Nearly 20% in Q4 2023: Pitchbook

BioSpace

Tue, 03/5/24 - 10:26 pm

venture capital

Nocion, chasing GSK, pulls in $62M for chronic cough drug

BioPharma Dive

Mon, 03/4/24 - 11:44 pm

FogPharma pulls in $145M to support cancer drug research

BioPharma Dive

Mon, 03/4/24 - 11:10 am

Gilead Secures $210M from VC to Build Trodelvy’s Clinical Case in NSCLC

BioSpace

Fri, 03/1/24 - 11:48 am

Gilead Sciences

non-small cell lung cancer

FogPharma clears $145M series E thanks to Alexis Borisy, ex-J&J CEO Alex Gorsky

Fierce Biotech

Fri, 03/1/24 - 11:46 am

Pages